Professor of Applied Health Economics and Director, Health Economics Consulting, UEA
Professor of Applied Health Economics
and Director, Health Economics Consulting, UEA
R dot Fordham at uea dot ac dot uk
Tel: +44 (0)1603 59 3543
|Chancelors Drive Seminar Annex 1.13|
My goal is to span the understanding between academic and professional realms. I am an applied economist, research practitioner and teacher who uses economic methods in working alongside other
disciplines in the interests of building better health systems in the real world.
I have worked both in the NHS as a manager and consulted to various NHS bodies. I have also worked in the Australian and German health systems. As a former Associate Dean for Knowledge
Transfer I work with my clients in solving their actual problems and finding them the best possible solutions.
My early years were spent working at the Institute of Social and Economic Research,York for Alan Williams from whom I learned the art of 'working with what one has, not what one would necessarily
like' but in the most rigorous ways possible!
Professional Qualifications and professional memberships
Ric’s research covers the development of priority setting techniques in complex decision making environments and he has adapted these for appropriate use in the practice of public health and World Class commissioning. His other work covers the use of economic evaluation techniques in wider public health and social issues such as obesity and food consumption, physical activity, drug and alcohol mis-use, parenting programmes, assistive technologies and other social care interventions. Throughout all these investigations he is interested in identifying, attributing and measuring the widest possible set of social and economic costs and benefits derived from these types of programme.
Ric has a longstanding interest too in the economics of orthopaedics and associated quality of life (the subject of his PhD). He is a Co-investigator and lead Health Economist on the MRC’s SCCOP project, an multi-centre economic evaluation of screening for osteoporosis in elderly women.
Abubakar I, L Irvine, CF Aldus, GM Wyatt, RJ Fordham, S Schelenz, L Shepstone, A Howe, M Peck, PR Hunter. (2007) ‘A systematic review of the clinical, public health and cost-effectiveness of rapid diagnostic tests for the detection and identification of bacterial intestinal pathogens in faeces and food’. Health Technology Assessment Sep;11(36):1-216
Fordham RJ, Jones L, Sumnall HR, McVeigh J, Bellis MA. (2007) ‘The economics of preventing drug use: an introduction to the issues’ National Collaborating Centre for Drug Prevention of the National Institute of Health and Clinical Excellence ISBN 978-1-902051-505
Wilson E, Sussex J, Macleod & Fordham RJ. (2007) ‘Prioritizing health technologies in a Primary Care Trust’ J. Health Services Research and Policy Vol.12, No.2 April 2007
Wilson E, Fordham RJ. (2006) ‘Essential Thrombocythaemia: anagrelide or interferon-α? A cost-utility analysis’. Haematologica 91(s1):300
Heller R, Gemmel I, Wilson E, Fordham RJ, Smith RD. (2006) ‘Using economic analyses for local priority setting: the population cost-impact approach’. Journal of Applied Health Economics and Health Policy 5(1):45-54
Wilson E, Rees J & Fordham RJ. (2006) ‘Developing a prioritization framework in an English Primary Care Trust’ Cost Effectiveness and Resource Allocation (17.2.06), 4:3 & Open Access see: http:/www.resource-allocation.com/content/4/1/3
Miles S, Fordham RJ, Mills C, Valovirta E, Mugford M. (2005) ‘A framework for measuring the costs to society of IgE-mediated food allergy’ Allergy 60: 996-1003
Loxley W, Fordham RJ et al. (2004) ‘The prevention of substance use, risk and harm in Australia - a review of the evidence’. Ministerial Council on Drug Strategy monograph, Australian Government Department of Health and Ageing ISBN:0 642 82482 7
Senior Lecturer for Health Economics at Norwich Medical School. MBBS medical degree.
Marsh, K, Phillips, CJ, Fordham, R, Bertranou, E and Hale, J (2012) Estimating cost-effectiveness in public health: a summary of modelling and valuation methods. Health Economics Review, 2 (1). p. 17. ISSN 2191-1991
Nisser, A, Fordham, RJ, Abubakar, I and Bachmann, M (2011) The provider cost of treating tuberculosis in Bauchi State, Nigeria. Journal of Public Health in Africa, 2 (2).
Phillips, CJ, Fordham, RJ, Marsh, K, Bertranou, E, Davies, S, Hale, J, Kingsley, M, Parke, S, Porteous, C, Rance, J and Warm, D (2011) Exploring the role of economics in prioritization in public health: what do stakeholders think? European Journal of Public Health, 21 (5). pp. 578-584.
Fordham, RJ, Lambert, RA and Large, S (2010) Do referrals by NHS Direct save the NHS money? A cost-minimalisation study of 1,001 NHS Direct users. BMJ.
Fordham, RJ, Smith, G, Jackowieiz, and Hornbuckle, J (2010) Cost of Gestational Diabetes mellitus. Medical Journal of Australia. (Unpublished)
Marsh, K, Phillips, C and Fordham, RJ (2010) Developing a framework for economic evaluations in public health. (Unpublished)
Ball, H, Kemp, L and Fordham, RJ (2009) Road testing PBMA in three English regions: the Norfolk Mental Health PBMA Pilot. The Psychiatric Bulletin, 33 (1). pp. 141-144.
Fordham, RJ, Maskell, D and Ruggles, R (2009) A pilot costing study of carbon monoxide poisoning in London. Clinical Hazards and Poisons report.
Fordham, RJ (2008) Economic assessment of carbon monoxide poisoning: strategies and options. Clinical Hazards and Poisons report, 12. ISSN 1745 3763
Abubakar, II, Irvine, L, Aldus, CF, Wyatt, GM, Fordham, RJ, Schelenz, S, Shepstone, L, Howe, AC, Peck, M and Hunter, PR (2007) A systematic review of the clinical, public health and cost-effectiveness of rapid diagnostic tests for the detection and identification of bacterial intestinal pathogens in faeces and food. Health Technology Assessment , 11 (36). pp. 1-216.
Keogh-Brown, MR, Fordham, RJ, Thomas, KS, Bachmann, MO, Holland, RC, Avery, AJ, Armstrong, SJ, Chalmers, JR, Howe, AC, Rodgers, S, Williams, HC and Harvey, IM (2007) To freeze or not to freeze: a cost-effectiveness analysis of wart treatment. British Journal of Dermatology, 156 (4). pp. 687-92.
Wilson, E, Jayne, DR, Dellow, E and Fordham, RJ (2007) The cost-effectiveness of mycophenolate mofetil (MMF) as firstline therapy in active lupus nephritis. Rheumatology (Oxford), 46 (7). pp. 1096-1101.
Wilson, E, Sussex, J, Macleod, C and Fordham, RJ (2007) Prioritizing Health Technologies in a Primary Care Trust. Journal of Health Services Research and Policy, 12 (2). pp. 80-85.
Fordham, RJ and Sussex, J (2006) How do we know if public health funding delivers. British Journal of Health Care Management, 12 (2).
Heller, RF, Gemmel, I, Wilson, E, Fordham, RJ and Smith, RD (2006) Using Economic Analyses for Local Priority Setting: The Population Cost Impact Approach. Applied Health Economics and Health Policy, 5 (1). pp. 45-54.
Thomas, KS, Keogh-Brown, MR, Chalmers, JR, Fordham, RJ, Holland, RC, Armstrong, SJ, Bachmann, MO, Rodgers, S, Avery, AJ, Harvey, I and Williams, HC (2006) Effectiveness and cost-effectiveness of salicylic acid and cryotherapy for cutaneous warts. An economic decision model. Health Technol Assess, 10 (25). pp. 1-104.
Wilson, E and Fordham, RJ (2006) Essential Thrombocythaemia: anagrelide or interferon- ? A cost-utility analysis. Haematologica, 91 (Suppl 1). p. 300.
Wilson, E, Rees, J and Fordham, RJ (2006) Developing a prioritisation framework in an English Primary Care Trust. Cost Effectiveness and Resource Allocation, 4. p. 3.
Miles, S, Fordham, RJ, Mills, C, Valovirta, E and Mugford, M (2005) A framework for measuring costs to society of IgE-mediated food allergy. Allergy, 60 (8). pp. 996-1003.
Fordham, RJ (2004) Could international imitation cure the NHS? CamPAIN, 15.
Brambleby, P and Fordham, RJ (2003) Implementing PBMA. Evidence Based Medicine. What is Series.
Brambleby, P and Fordham, RJ (2003) What is PBMA? Evidence Based Medicine: 'What is ' series.
Fordham, RJ (2003) Cost-benefit evaluation of drug interventions. The prevention of substance use, risk and harm in Austrailia: a review of evidence.
Smith, RD and Fordham, RJ (2001) Economics of fall prevention programmes: evidence and research priorties. Expert Review of Pharmacoeconomics & Outcomes Research, 1 (1). pp. 59-67.
Stockwell, T, Chkritzhs, T, Hendrie, D, Fordham, RJ, Ying, F, Phillips, M, Cronin, J and O'Reilly, B (2001) The public health and safety benefits of the northern territory's living with alcohol programme. Drug and Alcohol Review, 20 (2). pp. 167-180.
Fordham, RJ, Northey, K, Lawrence, D, Silburn, S and Zubrick, S A cost effectiveness analysis of a behavioural family intervention in preventing behaviour problems in children. Prevention Sciences. (In Press)
Lister, G, Fordham, RJ, Mugford, M, Olukoga, A, Wilson, E and McVey, D (2009) Evaluating the societal costs of potentially preventable illnesses: Developing a common approach. In: Future Public Health: Burdens, Challenges and Opportunities. London: Palgrave, pp. 233-247. ISBN 0230013597
Fordham, RJ (2008) Towards Investment in Public Health: The Emergence of a Burden of Economic Proof. In: Future Public Health: Burdens, Challenges and Opportunities. Palgrave, Cambridge, England, pp. 265-275. ISBN 0230013597
Fordham, RJ and Barton, GR (2008) 'A cost-effectiveness scenario analysis of four interventions to increase child and adolescent physical activity: the case of walking buses, free swimming, dance classes and community sports.' 'Promoting physical activity for children.' PDG Report, NICE. Research Report. UNSPECIFIED.
McDonald, E. A. and Fordham, RJ (2008) Practice Based Commissioning. Research Report. Care Services Improvement Partnership.
Fordham, RJ, Jones, L, Sumnall, HR, McVeigh, J and Bellis, MA (2007) The economics of preventing drug use: an introduction to the issues. National Collaborating Centre for Drug prevention of the National Institute of Health and Clinical Excellence. Research Report. UNSPECIFIED.
Sussex, J, Wilson, E and Fordham, RJ (2004) Prioritisation of health technologies in Huntingdonshire PCT (2): Report of workshop Friday 29 October 2004. Research Report. UNSPECIFIED.
Wilson, E and Fordham, RJ (2004) Commissioning Health Services in West Norfolk Primary Care Trust: A tool for evidence based and cost-effective commissioning. Research Report. UNSPECIFIED.
Fordham, RJ and Streather, M (2002) Total hip replacement - time for review? Research Report. UNSPECIFIED.
Fordham, RJ and Joyce, R (2001) Improving access for ENT services in Cambridgeshire Health Authority - a case study for Huntingdon PCT. Research Report. UNSPECIFIED.
Fordham, RJ (2006) What have QALYs ever done for public health? The dilemma of shifting priorities towards the well. In: Policy Futures for the UK Health Workshop : The future of health: burdens, challenges and opportunities.
Fordham, RJ, Silburn, S, Zubrick, S, Ward, K, Williams, A and Lawrence, D (2006) A cost-effectiveness analysis of a Behavioral Family Intervention in preventing behavior problems in children. In: National Investment for the Early Years (NIFTeY) Prevention: invest now or pay later, Sydney.
Wilson, E and Fordham, RJ (2006) Essential thrombocythaemia: Anagrelide or interferon-alfa? A cost-utility analysis. In: European Haematological Association, Amsterdam.
Fordham, RJ (2004) A multi-criteria analysis approach to commissioning - practical dilemmas in priority setting. In: Economics priority setting and health care funding: from principle to practice, Wellington, New Zealand.
Fordham, RJ (2004) A multi-dimensional criteria approach to a priority setting. In: Health Economics Study Group Researchers in Assessment, Glasgow.
Fordham, RJ (2002) Workplace health. what works, what doesn't and whats the return. In: Worksafe Australia, Perth, Australia.
Loxley, W and Fordham, RJ (2004) The prevention of substance use, risk and harm in Australia - a review of the evidence. Ministerial Council on Drug Strategy, Monograph, Australian Government Department of Health and Ageing. ISBN 0642824827
Send this page to your mobile phone by scanning this code using a 2D barcode (QR Code) reader. These can be installed on most modern Smart Phones.